ArticleDiabetes & vascular disease research
EMMPRIN aggravates angiogenesis and blood-retina barrier injury by regulating matrix metalloproteinases in diabetic retinopathy.
Jie Zhong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.